79330277 - GP GETEIN BIOTECH, INC.

Information

  • Trademark
  • 79330277
  • Serial Number
    79330277
  • Registration Number
    7141193
  • Filing Date
    November 17, 2021
    4 years ago
  • Registration Date
    August 22, 2023
    2 years ago
  • Transaction Date
    December 11, 2023
    2 years ago
  • Status Date
    August 22, 2023
    2 years ago
  • Published for Opposition Date
    June 06, 2023
    2 years ago
  • Location Date
    August 22, 2023
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KLUWE, CHERYL D
  • Attorney Docket Number
    BrightIP235
    Attorney Name
    Timothy T. Wang
    Law Office Assigned Location Code
    N80
  • Owners
Mark Drawing Code
3000
Mark Identification
GP GETEIN BIOTECH, INC.
Case File Statements
  • DM0000: The mark consists of the wording "GP GETEIN BIOTECH, INC.", "GP" formed by horizontal lines and appearing to the left of "GETEIN BIOTECH, INC.".
  • GS0051: Medicines for human purposes, namely, medicines for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; biological preparations for medical purposes, namely, preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; diagnostic preparations for medical purposes; biochemical preparations for medical use, namely, preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Medicated serums for treatment of viral infections, diseases of the blood system, diseases of the immune system, skin diseases, diseases caused by bacterial exotoxins, bacterial infections, fungal infections, parasitic infections; chemical preparations for medical purposes, namely, for cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Drugs for medical purposes for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Pharmaceutical preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; vaccines; dietetic substances adapted for medical use
  • TR0010: The wording "GETEIN" has no meaning in a foreign language.
  • GS0101: Diagnostic testing apparatus for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers for medical purposes; diagnostic apparatus for use in medical analysis of blood; surgical apparatus and instruments; blood testing apparatus; galvanic therapeutic appliances for wound healing; Diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers; Medical apparatus and instruments, namely, for cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases diagnosis; urological apparatus and instruments for surgery, diagnostic testing, treatment, adjuvant therapy; X-ray apparatus for medical purposes
  • D10000: "BIOTECH, INC."
Case File Event Statements
  • 12/11/2023 - 2 years ago
    32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 11/22/2023 - 2 years ago
    31 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/22/2023 - 2 years ago
    30 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/22/2023 - 2 years ago
    29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/22/2023 - 2 years ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 8/22/2023 - 2 years ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/25/2023 - 2 years ago
    26 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 6/7/2023 - 2 years ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 6/7/2023 - 2 years ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 6/6/2023 - 2 years ago
    23 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 6/6/2023 - 2 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/6/2023 - 2 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/17/2023 - 2 years ago
    20 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/17/2023 - 2 years ago
    19 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 5/17/2023 - 2 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/4/2023 - 2 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/4/2023 - 2 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/4/2023 - 2 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/4/2023 - 2 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/4/2023 - 2 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/27/2023 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/27/2023 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/27/2023 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/21/2022 - 3 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/3/2022 - 3 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/3/2022 - 3 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/10/2022 - 3 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/9/2022 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/29/2022 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/11/2022 - 4 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/7/2022 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/6/2022 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR